Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 4 Immune parameters before and after walking in CMV seropositive and seronegative participants

From: Changes in peripheral immune cell numbers and functions in octogenarian walkers – an acute exercise study

 

CMV+

CMV-

Before

After

Before

After

Hemoglobina (mmol/L)

8.4 (7.7–9.4)

7.9 (7.3–8.7)**

8.9 (7.9–9.0)

8.7 (7.5–9.1)

CRP (mg/L)

1 (1–9)

1 (1–10)

1 (1–6)

9 (1–47)

Leukocytes (109/L)

6.6 (4.6–11.0)

7.9 (5.7–14.3)**

6.6 (4.8–9.1)

7.2 (6.3–12.3)*

Neutrophils (109/L)

3.8 (2.4–8.3)

5.0 (2.9–10.4)*

4.2 (3.2–6.6)

5.1 (4.2–9.2)*

Eosinophils (109/L)

0.12 (0.03–0.68)

0.19 (0.06–0.78)**

0.17 (0.08–0.28)

0.15 (0.08–0.33)

Basophils (109/L)

0.03 (0.01–0.06)

0.03 (0.02–0.05)

0.05 (0.02–0.07)

0.04 (0.03–0.05)

Monocytes (109/L)

0.48 (0.29–0.69)

0.68 (0.40–1.05)**

0.57 (0.32–0.90)

0.66 (0.42–1.21)

Lymphocytes (109/L)

1.65 (1.45–2.21)

2.19 (1.33–2.97)**

1.37 (1.00–1.92)

1.40 (1.07–2.08)

CD3+ T cells (109/L)

0.77 (0.49–1.36)

1.19 (0.73–1.98)**

0.63 (0.20–1.00)

0.76 (0.48–1.45)

CD4+ T cells (109/L)

0.52 (0.17–0.99)

0.73 (0.40–1.62)**

0.40 (–0.06–0.69)

0.57 (0.37–0.87)

CD8+ T cells (109/L)

0.21 (0.04–0.45)

0.21 (0.06–0.72)*

0.08 (0.04–0.17)

0.10 (0.05–0.19)

CD19+ B cells (109/L)

0.26 (0.09–0.40)

0.35 (0.11–0.51)*

0.10 (0.05–0.40)

0.16 (0.09–0.45)*

CD16 + CD56+ NK cells (109/L)

0.32 (0.21–0.87)

0.31 (0.13–0.70)

0.43 (0.38–0.52)

0.29 (0.22–0.43)*

  1. CMV+ subjects (n = 13) and CMV- subjects (n = 7). Medians and range are shown. Paired analysis was peformed separately for CMV+ and CMV- subjects before and after excersise. Statistical significance by Wilcoxon signed rank test is indicated as *p < 0.05 or **p < 0.01
  2. aChanges in plasma volumes estimated according to Dill and Costill were not significantly different between CMV+ and CMV- subjects